Skip to main content
. Author manuscript; available in PMC: 2018 Sep 15.
Published in final edited form as: J Infect Dis. 2017 Sep 15;216(Suppl 4):S539–S547. doi: 10.1093/infdis/jix093

Table 1.

Periods of Prevalence for sH3N2 Viruses Used in Current Study

Reference Strain (Abbreviation) Eras of Prevalencea Prominent Seasonsb Vaccine-Use Erasa
A/Aichi/2/1968 (AI/68) 1968–1972 1968–1969; 1969–1970; 1971–1972 1968–1969; 1969–1970; 1970–1971; 1971–1972; 1972–1973
A/Victoria/3/1975(VIC/75) 1975–1977 1975–1976 1976–1977; 1977–1978
A/Bangkok/1/1979(BK/79) 1979–1983 1980–1981; 1982–1983 1980–1981; 1981–1982; 1982–1983;
A/Shanghai/11/1987(SH/87) 1987–1990 1987–1988; 1989–1990 1989–1990
A/Beijing/32/1992(BJ/92) 1992–1996 1992–1993; 1993–1994 1993–1994
A/Wuhan/359/1995(WH/95) 1995–1998 1996–1997 1996–1997; 1997–1998
A/Sydney/5/1997(SY/97) 1997–2000 1997–1998; 1998–1999; 1999–2000 1998–1999; 1999–2000
A/Fujian/411/2002(FJ/02) 2002–2005 2003–2004 2004–2005
A/Brisbane/10/2007(BR/07) 2007–2009 2007–2008 2008–2009; 2009–2010

Abbreviation: sH3N2, human seasonal influenza A(H3N2).

a

Data from previous publications [34, 35] and annual US influenza virus surveillance data.

b

Prominent influenza seasons were defined as those in which ≥20% of isolates typed and subtyped in that season were the sH3N2 virus [35].